POSC Stock UPDATES Positron Corp (POSC) 0.0052 08/20/2014 14

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Positron Corp (POSC) 0.0052 $POSC

Breast Imaging Technologies Market Worth $3 Billion by 2019 - New Report by MarketsandMarkets
PRWeb - Mon Aug 18, 7:07AM CDT
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Global Positron Emission Tomography Market: Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
PRWeb - Sun Aug 10, 8:01AM CDT
Positron emission tomography (PET) is a nuclear medicine imaging procedure that is used to monitor various internal body organs and tissues in order to identify certain disease conditions. PET imaging procedure provides a better insight about the working condition of organs and tissues, size, shape and position. PET is most widely used by oncologists in order to diagnose various types of cancer; neurologists in order to diagnose neurological disorders and cardiologists in order to diagnose cardiovascular diseases. Ongoing developments in this area are likely to begin its use in other specialties as well. This is also performed in order to assess the progress of the treatment of certain diseases. This procedure is different from magnetic resonance imaging (MRI) and computed tomography (CT) as they only show the tissue structure and blood flow to and from organs. This imaging procedure is also being used in combination with other diagnostic technologies such as CT with an aim to provide more precise information about various neurological, cardiovascular and cancer diseases.

Breast Imaging Technologies Market worth $3 Billion by 2019
M2 - Mon Aug 04, 3:17AM CDT
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging...) - Global Forecasts to 2019
PR Newswire - Mon Jul 21, 8:05AM CDT
Reportbuyer.com has added a new market research report:

Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019
M2 - Mon Jul 21, 3:08AM CDT
Report Description

Global Cytogenetics Report 2014 - Technologies, Markets and Companies to 2023
M2 - Fri Jul 18, 6:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bc7wtb/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering. The report includes summary profiles of 67 companies relevant to cytogenetics along with their 74 collaborations. Companies developing innovative technologies as well as those supplying equipment/services/reagents are identified.The report text is supplemented with 27 Tables and 9 figures. Selected 200 references are included in the bibliography. FISH remains the single most important technology in cytogenetics. Several innovations are described of which the most important are single copy FISH, in vivo FISH (imaging of nucleic acids in living cells) and nanotechnology-based FISH. The unique character of peptide nucleic acid (PNA) allows these probes to hybridize to target nucleic acid molecules more rapidly and with higher affinity and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies for cytogenetics promise to speed up detection of chromosome aberrations now examined by FISH. Other important genomic technologies are whole genome expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic applications. Optical Mapping can survey entire human genomes for insertions/deletions, which account for a significantly greater proportion of genetic variation between closely-related genomes as compared to single nucleotide polymorphisms (SNPs), and are a major cause of gene defects. Technologies encompassed within molecular imaging include optical imaging, magnetic resonance imaging (MRI) and nuclear medicine techniques. Positron emission tomography (PET) is the most sensitive and specific technique for imaging molecular pathways in vivo in humans. Cytogenetics can be refined by application of cytogenetics at single molecule level. Nanotechnology has facilitated the development of technology for single molecule imaging. Atomic force microscope (AFM) has become a well-established technique for imaging single biomolecules under physiological conditions. The scanning probe microscope (SPM) system is emerging as an increasingly important tool for non-intrusive interrogation of biomolecular systems in vitro and have been applied to improve FISH. Another example of application of nanobiotechnology is QD (quantum dot)-FISH probes, which can detect down to the single molecule level. Key Topics Covered: Executive Summary 1. Introduction 2. Technologies used for cytogenetics 3. Fluorescent In Situ Hybridization 4. Genomic Technologies relevant to Cytogenetics 5. Molecular Imaging & Single Molecular Detection 6. Role of Nanobiotechnology in Cytogenetics 7. Biomarkers and Cytogenetics 8. Applications of Cytogenetics 9. Cancer Cytogenetics 10. Cytogenetics Markets 11. Companies 12. References For more information visit http://www.researchandmarkets.com/research/bc...togenetics Source: Jain PharmaBiotech

Sofie Biosciences Partners with PerkinElmer to Deliver Benchtop PET In Vivo Imaging Systems to Preclinical Research Professionals
PR Newswire - Fri Jun 13, 5:06AM CDT
Sofie Biosciences, a leader in the field of PET imaging, and PerkinElmer Inc., today announced an agreement in which PerkinElmer will exclusively commercialize and sell preclinical Positron Emission Tomography (PET) - X-Ray and 3-dimensional Computed Tomography (CT) imaging systems developed by, or in conjunction with, Sofie Biosciences.

United Kingdom Nuclear Imaging Equipment Market Outlook to 2020
M2 - Mon Mar 24, 3:52AM CDT
Summary

Research and Markets: United States Nuclear Imaging Equipment Market Outlook to 2020
Business Wire - Thu Mar 20, 1:29PM CDT
Research and Markets (http://www.researchandmarkets.com/research/czfwn8/united_states) has announced the addition of the "United States Nuclear Imaging Equipment Market Outlook to 2020" report to their offering.

United States Nuclear Imaging Equipment Market 2020 Forecasts in New Research Report at RnRMarketResearch.com
PRWeb - Thu Mar 20, 11:04AM CDT
This report provides key market data on the United States Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).

United States Nuclear Imaging Equipment Market Outlook to 2020
M2 - Thu Mar 20, 10:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jckjng/united_states) has announced the addition of the "United States Nuclear Imaging Equipment Market Outlook to 2020" report to their offering. "United States Nuclear Imaging Equipment Market Outlook to 2020", provides key market data on the United States Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Nuclear Imaging Equipment market wherever available. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Nuclear Imaging Equipment Market, United States 3.1 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2005-2012 3.2 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2012-2020 3.3 Nuclear Imaging Equipment Market, United States, Volume (Units), 2005-2012 3.4 Nuclear Imaging Equipment Market, United States, Volume (Units), 2012-2020 3.5 Nuclear Imaging Equipment Market, United States, Average Price ($), 2005-2020 3.6 Nuclear Imaging Equipment Market, United States, Distribution Share by Revenue ($m), 2011-2012 3.7 Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), 2011-2012 4 Overview of Key Companies in United States, Nuclear Imaging Equipment Market 5 Nuclear Imaging Equipment Market Pipeline Products 6 Financial Deals Landscape 6.1 Acquisition 6.2 Asset Transactions 6.3 Equity Offerings 6.4 Partnerships 7 Recent Developments 7.1 Corporate Communications 7.2 Financial Announcements 7.3 Government and Public Interest 7.4 Other Significant Developments 7.5 Strategy And Business Planning 8 Appendix Companies Mentioned Philips Healthcare GE Healthcare Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/jc...ted_states

New Partnership Agreement with the National Association of Attorneys General
M2 - Tue Feb 25, 6:25AM CST
Ambassador William R. Brownfield, Assistant Secretary of State for the Bureau of International Narcotics and Law Enforcement Affairs (INL), signed a partnership agreement today with Attorney General J.B. Van Hollen of Wisconsin, President of the National Association of Attorneys General (NAAG). Under this partnership, NAAG's National Attorneys General Training and Research Institute and INL will cooperate on advancing the development of rule-of-law institutions with partner countries around the world.

Concise Analysis of the International Radiopharmaceuticals Market
M2 - Fri Feb 14, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/5ltj8g/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - France (2) - Germany (2) - The United Kingdom (4) - Italy (2) - Spain (1) - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5l...rmaceutica

Omeros Reports Additional Positive Phase 1 Clinical Data for OMS824 for the Treatment of Cognitive Disorders
PR Newswire - Tue Feb 11, 6:00AM CST
Omeros Corporation (NASDAQ: OMER) today announced additional positive data from its Phase 1 program for OMS824, the lead compound in Omeros' phosphodiesterase 10 (PDE10) program. This clinical trial evaluated the extent to which OMS824 binds to PDE10, an enzyme expressed in the region of the brain that has been linked to a wide range of diseases that affect cognition. In the latest cohort enrolled in this trial, OMS824 achieved a high of approximately 70--percent engagement at PDE10 without evidence of extrapyramidal symptoms (EPS). These data further support the potential of OMS824 to have a high therapeutic index in the treatment of patients with schizophrenia, Huntington's disease and other cognitive disorders. Omeros is completing a Phase 2a trial evaluating the drug in patients with schizophrenia and will start enrollment in a Phase 2 trial for Huntington's disease this quarter.

Cytogenetics Report - Technologies, Markets and Companies - 2014
M2 - Mon Feb 10, 10:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/m53hk3/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering. This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. Historical landmarks in the evolution of cytogenetics are reviewed since the first images of chromosomes were made in 1879. The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH. Molecular cytogenetics includes application of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection. Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies. FISH remains the single most important technology in cytogenetics. Several innovations are described of which the most important are single copy FISH, in vivo FISH (imaging of nucleic acids in living cells) and nanotechnology-based FISH. The unique character of peptide nucleic acid (PNA) allows these probes to hybridize to target nucleic acid molecules more rapidly and with higher affinity and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies for cytogenetics promise to speed up detection of chromosome aberrations now examined by FISH. Other important genomic technologies are whole genome expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic applications. Optical Mapping can survey entire human genomes for insertions/deletions, which account for a significantly greater proportion of genetic variation between closely-related genomes as compared to single nucleotide polymorphisms (SNPs), and are a major cause of gene defects. Technologies encompassed within molecular imaging include optical imaging, magnetic resonance imaging (MRI) and nuclear medicine techniques. Positron emission tomography (PET) is the most sensitive and specific technique for imaging molecular pathways in vivo in humans. Cytogenetics can be refined by application of cytogenetics at single molecule level. Nanotechnology has facilitated the development of technology for single molecule imaging. Atomic force microscope (AFM) has become a well-established technique for imaging single biomolecules under physiological conditions. The scanning probe microscope (SPM) system is emerging as an increasingly important tool for non-intrusive interrogation of biomolecular systems in vitro and have been applied to improve FISH. Another example of application of nanobiotechnology is QD (quantum dot)-FISH probes, which can detect down to the single molecule level. There are connections between cytogenetics and biomarkers of genetic disorders as well as cancer. Biomarkers are very important for molecular diagnostics. Not only are molecular diagnostic technologies used for discovery of biomarkers, biomarkers are the basis of several diagnostics. As a means to understand pathomechanism of disease and as links between diagnostics and therapeutics, biomarkers are playing a role in development of personalized medicine. Application of cytogenetics extend beyond genetic disorder and cancer to diagnosis of several other diseases. Other important applications are drug discovery, and development of personalized medicine. The chapter on markets provides a global perspective of the cytogenetics business in the major markets: US, Western Europe (including France, Germany, Italy, Spain, and the UK), and Japan. The total figures for the market are also broken out according to the technologies and major disease areas in which they are applied. Markets figure are given for the year 2013 and estimates are made for the years 2018 and 2023. Advantages and limitations of various technologies have been pointed out throughout the report but this chapter includes SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis of some of the competing technologies including the following: conventional FISH, innovative FISH technologies, PCR-based assays, and single molecule imaging. Unfulfilled needs in cytogenetics market are depicted graphically. Among various technologies, FISH is most advanced and less opportunities for further development than single molecule detection, which is in infancy and has more future potential. Key Topics Covered: Executive Summary 1. Introduction 2. Technologies used for cytogenetics 3. Fluorescent In Situ Hybridization 4. Genomic Technologies relevant to Cytogenetics 5. Molecular Imaging & Single Molecular Detection 6. Role of Nanobiotechnology in Cytogenetics 7. Biomarkers and Cytogenetics 8. Applications of Cytogenetics 9. Cancer Cytogenetics 10. Cytogenetics Markets 11. Companies 12. References For more information visit http://www.researchandmarkets.com/research/m5...togenetics Source: Jain PharmaBiotech

2013 Report on the International Radiopharmaceuticals Market - Trends And Forecasts to 2018
M2 - Thu Jan 23, 3:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/fhpj27/radiopharmaceutica) has announced the addition of the "2013 Report on the International Radiopharmaceuticals Market - Trends And Forecasts to 2018" report to their offering. There is tremendous growth potential the radiopharmaceuticals market, especially in developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal antibodies has opened new boulevards for the growth of the global radiopharmaceuticals market. Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many useful properties of gamma-emitting tracer nuclide. This report analyses the global scenario of the radiopharmaceuticals market, discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data, and forecasts the radiopharmaceuticals market size, production forecasts along with key factors driving and restraining the market. The report also analyzes the radiopharmaceuticals market by generators and by further classifying them in terms of medical isotopes, their applications, end users and geographic distribution. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Global Radiopharmaceuticals Market Overview 4 Market Definition & Supply Chain Analysis 4.1 Market Definition 4.2 Radiopharmaceutical Production : A Global Perspective 4.3 Supply Chain Analysis 5 Global Radiopharmaceutical Generators Market 5.1 Overview 5.2 Mo-99/Tc-99m Generators 5.3 Sr-82/Rb-82 Generators 5.4 Ge-68/Ga-67,68 Generators 5.5 Sr-90/Y-90 Generators 5.6 W-188/Re-188 Generators 6 Global Radiopharmaceuticals Market, By End-User Groups 6.1 Overview 6.2 Hospitals and Medical Centers 6.3 Outpatient Diagnostic Centers 7 Global Radiopharmaceuticals Market, By Applications 8 Global Radiopharmaceuticals Market, By Geography 8.1 Overview 8.2 North America 8.3 Europe 8.4 Asia-Pacific (Apac) 8.5 Rest of the World 9 Market Share Analysis By Key Players 9.1 Radiopharmaceuticals Market 9.2 Generators Market 10 Recommendations 10.1 Identification and Elimination Of Barriers 10.2 Development of Total Solutions 10.3 Investing in Emerging Markets 10.4 Entering Monopoly Markets 11 Company Profiles Companies Mentioned: - Cardinal Health - Covidien - GE Healthcare - IBA Group - Lantheus Medical Imaging - Monrol Nuclear Products - NTP Radioisotopes - Nordion - Polatom - Positron Corporation - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/fh...rmaceutica

Global Medical Imaging Equipment Market Report 2013-2019: In-Depth X-ray, Ultrasound, CT, MRI and Nuclear Imaging Analysis
M2 - Wed Jan 15, 9:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/wn7p65/medical_imaging) has announced the addition of the "Global Medical Imaging Equipment Market Report 2013-2019" report to their offering. The report studies the global medical imaging equipment market based on the various types of equipments (product categories) as well as the different technologies used in each product segment. The five major categories of imaging equipments studied in this report include X-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging equipments. The market has also been segmented into four major geographies of the world, namely, North America, Europe, Asia-Pacific and Rest of the World. The market sizes and forecasts for each segment of the market have been calculated for the period 2011-2019 considering 2012 as the base year and have been expressed in the report in terms of USD million. The CAGR % for the forecast period 2013 to 2019 has also been provided for each market segment and sub-segment. A detailed qualitative analysis of the market dynamics, based on factors like drivers, restraints and opportunities has been presented in the market overview section of the report. This section also includes the Porter's five force analysis and market attractiveness analysis by geography for the global medical imaging equipment market. Market share analysis by key players operating in this market has been included in terms of percent share in the year 2012, in the competitive landscape section of the report. Scope of the Report Product Types X-ray Devices - Stationary X-ray Devices - Portable X-ray Devices Computed Tomography (CT) Scanners - Stationary CT - Portable/Mobile CT Ultrasound Systems - Trolley/Cart based ultrasound - Compact/Portable ultrasound Magnetic Resonance Imaging (MRI) Equipment - Closed MRI - Open MRI Nuclear Imaging Equipment - Single Photon Emission Computed Tomography (SPECT) Scanners - Positron Emission Tomography (PET) Scanners Technology X-ray Devices - Analog - Computed radiography (CR) - Digital radiography (DR) Computed Tomography (CT) Scanners - Low-slice scanners - Medium-slice scanners - High-slice scanners Ultrasound Systems - 2-D Imaging - 3-D & 4-D Imaging - Doppler - HIFU - Lithotripsy Magnetic Resonance Imaging (MRI) Equipment - High-field - Medium-field - Low-field Nuclear Imaging Equipment - Single Photon Emission Computed Tomography (SPECT) - Positron Emission Tomography (PET) Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Medical Imaging Equipment Market, by Product Type, 2011 - 2019 (USD Million) Chapter 5 Global Medical Imaging Equipment Market, by Technology, 2011 - 2019 (USD Million) Chapter 6 Global Medical Imaging Equipment Market, by Geography, 2011 - 2019 (USD Million) Chapter 7 Competitive Landscape Chapter 8 Recommendations Chapter 9 Company Profiles - Carestream Health, Inc - Fonar Corporation - Fujifilm Holdings Corporation - GE Healthcare Ltd - Genesis Medical Imaging, Inc - Hitachi Medical Corporation - Hologic, Inc - Philips Healthcare - Samsung Medison Co Ltd - Shimadzu Corporation - Siemens Healthcare - Toshiba America Medical Systems Inc For more information visit http://www.researchandmarkets.com/research/wn...al_imaging




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 128

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Memorial Manor's Five-Star Signal in Long-Term Care

Updated Category News Views 81

Care quality is the only score that matters here A nursing home recognition is not the sort of news anybody should read like a trophy-case press release and then forget by lunch. Families make decisions around long-term care when they are tired, worried, and often dealing with a parent or spouse whose needs have changed fast. In that setting, a facility putting up both a...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 141

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 47

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 81

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 144

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 144

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading
Inhabit Puts AI Across Its Property Management Stack

Updated Category News Views 37

Property managers do not need another shiny chatbot; they need fewer dropped leads, fewer invoice-entry mistakes and less staff time burned chasing routine answers. That is the sensible hook in Inhabit's OPTECH 2026 announcement. The company is spreading AI, integrations and scalability work across ResMan, Anyone Home, ePremium, Nationwide Compliant and several adjacent...

Continue Reading

Top 5 Most Recently Viewed Articles

ADT Inc. Pricing for Secondary Offering and Share Repurchase

Updated Category News Views 210

ADT Inc. Moves Forward with Secondary Public Offering ADT Inc. (NYSE: ADT) has made waves in the financial world by announcing the pricing of a secondary public offering. This significant event involves 56 million shares of common stock that are being sold by certain entities associated with Apollo Global Management, Inc. The process is designed to provide liquidity and...

Continue Reading
Exciting Updates from illumin Holdings Regarding Q2 2025 Results

Updated Category News Views 176

Upcoming Financial Results Announcement Toronto and New York - illumin Holdings Inc. (TSX: ILLM, OTCQB: ILLMF), renowned in the digital advertising technology sector, is gearing up to present its second quarter 2025 financial outcomes. These results are set to be unveiled before market operations commence on an announced date. Join Us for the Live Webcast All interested...

Continue Reading
Exploring Growth in the Mining Remanufacturing Sector

Updated Category News Views 168

Understanding the Mining Remanufacturing Components Market This comprehensive analysis provides insights into the growth of the mining remanufacturing components market. It highlights the increasing demand for sustainable practices, innovations, and market dynamics. Market Size and Growth Rate The mining remanufacturing components market was valued at around US$ 4.20...

Continue Reading
Novo Nordisk's Wegovy Trial Success: Weight Loss Breakthrough

Updated Category News Views 787

Groundbreaking Results from Novo Nordisk's Wegovy® Trial The latest findings from Novo Nordisk indicate a significant breakthrough in weight management through the higher dose of Wegovy, which has delivered an impressive average weight loss of 21% for individuals suffering from obesity. The trial results, presented at a prominent diabetes conference, revealed that...

Continue Reading
Builders FirstSource Announces Leadership Transition Plans

Updated Category News Views 230

Leadership Changes at Builders FirstSource Builders FirstSource, Inc. (NYSE: BLDR) is undergoing a major leadership shift as part of a planned transition. The company has announced that Peter Jackson, who currently serves as the Chief Financial Officer, will step into the role of President and Chief Executive Officer. This change marks an important milestone in the...

Continue Reading